Epidemiological characteristics of mortality due to bacterial meningitis in Paraguay (2015 – 2019)
DOI:
https://doi.org/10.53732/rccsalud/04.02.2022.01Keywords:
meningitis, mortality, cerebrospinal fluidAbstract
Introduction. Meningitis is a disease that requires immediate diagnosis and treatment. The epidemiology changed over the years due to the advances in conjugate vaccines, however, the mortality rate, as well as the disease burden, are still very high. Objective. To describe the epidemiological characteristics of meningitis mortality in Paraguay in the 2015-2019 period. Materials and methods. Descriptive and ecological study in which data was obtained from the open and official website of the General Department of Strategic Information of the Ministry of Public Health and Social Welfare. Crude and adjusted rates (per 100,000 inhabitants) were calculated using Excel and EPI INFO 7.0. Results. In the study period, 125 deaths were registered with the highest prevalence in 2018 (adjusted rate of 0.55 per 100,000 inhabitants) and the lowest in 2017 (adjusted rate of 0.27 per 100,000 inhabitants). The months with the highest mortality were August and December with 15.2% and 11.2%, respectively. Males were the predominant gender with 58.40% (73 people), 21.60% (27) were under 4 years of age, mostly women, and 12% (11) were seniors (60-70 years), mostly men. Average age was 37.76 years, 67.20% single (84) and 26.40% (33) had no formal education and 80.80% (101) lived in urban areas. The highest rates were registered in Paraguarí (6.8 per 100,000 inhabitants) and Caazapa (3.3 per 100,000 inhabitants). There were no cases in Alto Paraguay. Conclusion: The extremes of life remain a vulnerable population for meningitis.
References
Domínguez-Gil M, Artero A, Oteo JA, Eiros JM. Virología: diagnóstico sindrómico de meningitis y encefalitis. Enferm Infecc Microbiol Clin. 2020;38(Supl1):19–23. 10.1016/j.eimc.2020.02.004
Trocha G, Ramírez N, Cerón N, Romero C. Meningitis bacteriana aguda del adulto adquirida en la comunidad. Acta Neurológica Colomb. 2021;37(1):55–63. 10.22379/24224022335
Morales-Casado MI, Julián-Jiménez A, Lobato-Casado P, Cámara-Marín B, Pérez-Matos JA, Martínez-Maroto T. Factores predictores de meningitis bacteriana en los pacientes atendidos en urgencias. Enferm Infecc Microbiol Clin. 2017;35(4):220–8. 10.1016/j.eimc.2016.02.007
Leguizamón R, Guillén MC, Gómez G, Vega Bogado ME. Meningitis en el Hospital Nacional. Rev. Nac. 2017;9(1):61–77. 10.18004/rdn2017.0009.01.061-077
Koelman DLH, van Kassel MN, Bijlsma MW, Brouwer MC, van de Beek D, van der Ende A . Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: 3 Decades of National Meningitis Surveillance in The Netherlands. Clin Infect Dis. 2021;73(5):e1099–107. 10.1093/cid/ciaa1774
Acevedo R, Bai X, Borrow R, Caugant D et al. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18(1):15–30. 10.1080/14760584.2019.1557520
Rivero Calle I, Rodriguez-Tenreiro Sánchez C, Martinón-Torres F. Vacunas antimeningocócicas. Situación epidemiológica mundial y estrategias de prevención mediante la vacunación. Enferm Infecc Microbiol Clin. 2015;33(4):257–67. 10.1016/j.eimc.2015.03.001
Kloek AT, Brouwer MC, Schmand B, Tanck MWT, van de Beek D. Long-term neurologic and cognitive outcome and quality of life in adults after pneumococcal meningitis. Clin Microbiol Infect. 2020;26(1):1361–7. 10.1016/j.cmi.2020.01.020
León ME, Kawawaba A, Nagai M, Rojas L, Chamorro G. Genotipos de Neisseria meningitidis aislados de pacientes con enfermedad meningocócica en Paraguay, 1996-2015. Rev Panam Salud Pública. 2019;43(6):310. 10.26633/RPSP.2019.10
Deloria Knoll M, Bennett JC, Garcia Quesada M, et al. Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project. Microorganisms. 2021;9(4):742. 10.3390/microorganisms9040742
Olivera Leal IR, Gómez Viera N, Ruiz García D, Riol JM. Caracterización clínica de pacientes con infecciones del sistema nervioso central en un centro de atención terciaria. Rev Cubana Med. 2020;59(3):e1342. http://www.revmedicina.sld.cu/index.php/med/article/view/1342
Van de Beek D, Brouwer MC, Koedel U, Wall EC. Community-acquired bacterial meningitis. Lancet. 2016;398(10306):1171–83. 10.1016/S0140-6736(21)00883-7
Arbo A. Neisseria meningitidis: Importancia del conocimiento de la epidemiología anticipando la disponibilidad de vacunas efectivas. Rev Inst Med Trop. 2015;10(1):1–3. 10.18004/imt/20151011-3
Aranda C, Lovera D, Arbo A. Cambios en el Patrón Epidemiológico y resistencia Bacteriana de la Meningitis Bacteriana Aguda en Niños en un hospital de referencia. Rev del Inst Med Trop. 2014;9(2):10–20. scielo.iics.una.py//scielo.php?script=sci_arttext&pid=S1996-36962014000200003&lang=es
Ministerio de Salud Pública y Bienestar Social. Dirección General de Información Estratégica en Salud (DIGIES). 2021. http://portal.mspbs.gov.py/digies/06-serie-historicas-indicadores-mortalidad-indimor/
Ministerio de Salud Pública y Bienestar Social. Dirección General de Vigilancia de la Salud. Programa nacional de enfermedades inmunoprevenibles y PAI. Normas nacionales de vacunación, técnico administrativas y de vigilancia del programa nacional de enfermedades inmunoprevenibles y PAI. 2016 https://paraguay.bvsalud.org/wp-content/uploads/2018/11/normasdelpai2016selection1.pdf
Amarilla S, Lovera D, Martínez de Cuellar C, Araya S, Aranda C, Chamorro G, et al. Epidemiología, clínica y factores pronósticos de Enfermedad Meningocóccica Invasora en un centro de referencia de Paraguay. 2005 a 2018. Rev Inst Med Trop. 2018;13(1):41–54. 10.18004/imt/201813140-53
Scarella JP, Cubillos JA, Garrido C, Briceño V, Armijo J, Martínez F. Prevalencia de agentes etiológicos de meningitis bacteriana en población adulta en el Hospital San Martín de Quillota entre los años 2012-2018. Rev Chil Neuropsiquiatr. 2019;57(4):347–56. 10.4067/S0717-92272019000400347
Panamerican Health Organization PAHO. Crecimiento acelerado de la población adulta de 60 años y más de edad: Reto para la salud pública. 2021. https://www.paho.org/en/news/28-9-2012-crecimiento-acelerado-poblacion-adulta-60-anos-mas-edad-reto-para-salud-publica.
Ministerio de Salud Pública y Bienestar Social. Encuesta SABE. Principales Resultados junio 2018. Salud, Bienestar y Envejec. 2018. https://www.stp.gov.py/v1/wp-content/uploads/2019/04/Final_SABE-ASUNCION-REPORT_v2-1eng_spa.pdf
Ministerio de Salud Pública y Bienestar Social. Instituto Nacional de Estadística. Proyección de la Población Nacional, Áreas Urbana y Rural por Sexo y Edad, 2000-2025. DGEEC DG de EE y C. https://www.ine.gov.py/default.php?publicacion=2.
Wahl B, O'Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health. 2018;6(7):e744-e757. https://doi.org/10.1016/S2214-109X(18)30247-X
.png)
All the contents of this journal are licensed under a 